Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants
MSphere 2.6 (2017): e00501-17.
Frese, Steven A., et al.
Analysis of fecal samples of a subset of infants from a randomized open-label trial to determine the effects of supplementing the probiotic Bifidobacterium longum subsp. infantis for the first 21 days. Study finds significantly higher abundance of B. infantis (by qPCR) and relative abundance of Bifidobacterium (by 16S rRNA sequencing) in infants fed with B. infantis EVC001 relative to the microbiome exclusively breasted control infants.
Related content in Publications
Frontiers in Nutrition 7 (2020): 33
Integrating the ecosystem services framework to define dysbiosis of the breastfed infant gut: the ro...Read more
FEMS Microbiology Letters 367.6 (2020): fnaa032
Reintroducing B. infantis to the cesarean‐born neonate: an ecologically sound alternative...Read more
Scientific Reports 11.1 (2021): 1472
Metagenomic insights of the infant microbiome community structure and function across multiple sites...Read more
Pediatric research 77.1 (2015): 229-235